Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CSIS WARRANT SERIES I (CSIS-W) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

CSIS WARRANT SERIES ITrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

CSIS WARRANT SERIES I vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? CSIS WARRANT SERIES I trades at Rp85 (market cap 4.6B, 4.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 74.8K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 36.4× CSIS WARRANT SERIES I's market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (74.8K versus 4.2K). Which is the better fit depends on your goals.

CSIS-WOBAT
Market Cap
4.6B167.37B
Volume
4.2K74.8K
Lot
42748
Turnover
357.3K18.41M
Average Price
85.07246.12
Value
357.3K18.41M
Indicative Equilibrium Price
246
Indicative Equilibrium Volume
2.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OBAT
View details

About CSIS WARRANT SERIES I

PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.

Read more on CSIS-W

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT